[1] MARA K, ALEXANDRA J S,YANNICK B, et al. Beyond the usual suspects: Hepatitis E virus and its implications in hepatocellular carcinoma[J].Cancers,2021,13(22):5867.
[2] HARRIET R,MELINA A,JACQUES F, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J].J Hepatol,2022,77(6):1598-1606.
[3] HYUNA S, JACQUES F, REBECCA L S, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[4] LHOMME S,MIGUERES M,ABRAVANEL F, et al. Hepatitis E virus: How it escapes host innate immunity[J].Vaccines(Basel),2020,8(3):422.
[5] MALICK A A D,SEYNABOU L,MOMAR C N, et al. Hepatitis E virus seroprevalence and associated risk factors in pregnant women attending antenatal consultations in senegal[J].Viruses,2022,14(8):1742.
[6] 赵庆江,田大广.肝细胞癌临床诊疗的研究进展[J].中国社区医师,2023,39(11):11-13.
[7] BRAY F,FERLAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(5):394-424.
[8] NIMGAOKAR I,DING Q, SCHWARTZ R E, et al. Hepatitis E virus: advances and challenges[J].Nat Rev Gastroenterol Hepatol,2018,15(2):96-110.
[9] ASRANI S K, DEVARBHAVI H, EATON J, et al. Burden of liver diseases in the world[J].J Hepatol,2019,70(1):151-171.
[10] 朱荣.江苏省戊型病毒性肝炎流行特征分析[J].江苏预防医学,2006,17(3): 27.
[11] 田轩,宋红丽.肝移植治疗成人戊型病毒性肝炎的临床现状[J].实用器官移植电子杂志,2021,9(1):85-88.
[12] PAS S D, STREEFKERK R H R A, PRONK M,et al.Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients[J].J Clin Virol,2013, 58(4):629-634.
[13] TANG Z M,WEN G P, YING D, et al. Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study[J].Emerg Microbes Infect,2023,12(1):2140613.
[14] SHEN C,JIANG X,LI M, et al. Hepatitis virus and hepatocellular carcinoma: recent advances[J].Cancers,2023,15(2):533.
[15] VITO R, BARBARA R. The liver as an immunological organ[J].Hepatology,2006,43(2 Suppl 1):S54-S62.
[16] SRIVASTAVA R,AGGARWAL R,BHAGA R M, et al. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E[J].J Viral Hepat,2008,15(12):910-916.
[17] TAKEUCHI O, AKIRA S. Pattern Recognition Receptors and Inflammation[J].Cell,2010,140(6):805-820.
[18] 李晓领,张青,王李安,等.戊型肝炎病毒感染的免疫发病机制[J].临床肝胆病杂志,2022,38(7):1629-1633.
[19] SCHNEIDER W M,CHEVILLOTTE M D,RICE C M. Interferon-stimulated genes: a complex web of host defenses[J].Annu Rev Immunol,2014,32:513-545.
[20] WILLIAM B,HEATHER B, YIN X, et al. Resolution of hepatitis E virus infection in CD8+ T cell depleted rhesus macaques[J].J Hepatol,2021,75(3):557-564.
[21] WONG P,PAMER G E.CD8+ T cell responses to infectious pathogens[J].Ann Rev Immunol,2003,21(1):29-70.
[22] HOAN X N,TONG V H,HECHT N, et al. Hepatitis E virus superinfection and clinical progression in hepatitis B patients[J].EBioMedicine,2015,2(12):2080-2086.
[23] ABDOLREZA J S,MORTEZA P. Hepatitis E virus and serum level aminotransferases in blood donors[J].Rep Biochem Mol Biol,2013,2(1):48-51.
[24] YANG Y, SHI R, SOOMRO M H,et al. Hepatitis E virus induces hepatocyte apoptosis via mitochondrial pathway in mongolian gerbils[J].Front Microbiol,2018,9:460.
[25] MARINE A A,Atangana P J A, DOMINIQUE N N,et al. Hepatitis E virus infection as a promoting factor forhepatocellular carcinoma in Cameroon: preliminary observations[J].Int J Infect Dis,2017,64:4-8.
[26] SHAH S M,BANIYA J B,GUPTA B P,et al.Short article: Association between liver fibrosis and hepatitis E seropr-evalence among HIV-positive individuals in Nepal[J].Eur J Gastroenterol Hepatol,2019,31:503-505.
[27] JARDI R, CRESPO M, HOMS M, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain[J].Hiv Med,2012, 13(6):379-383.
[28] ALISON M R, NICHOLSON L J, LIN W R. Chronic inflammation and hepatocellular carcinoma[J].Inflamm Gas Cancers,2011,185:135-148.
[29] MRZLJAK A,DINJAR-KUJUNDZIC P,JEMERSIC L, et al.The burden of hepatitis e infection in chronic liver diseases in croatia[J].Vector Borne Zoonotic Dis,2021,21(1):67-68.
[30] TSENG T C, LIU C J, CHANG C T, et al. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis[J].J Hepatol,2020,72(6):1105-1111.
[31] XUE M,LIN X N,LIN Q X, et al. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk[J].Int J Cancer,2021,148(12):2974-2981.
[32] IVO D,FAUSTA D,PARDHA D, et al. Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey[J].Hepatology,2014,60(3):815-822.
[33] ANDREAS K,MAHNAZ T,BORIS B, et al. Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection[J].Hepatol Res,2015,45(11):1146-1151.
2024, Vol. 41 
